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Abstract
Purpose To demonstrate that translocation carrier patients
can be identified by analysis of chromosomes in preimplan-
tation human embryos.
Methods A report of 3 cases in which multiple embryos were
found to possess consistent segmental imbalances by CCS.
The parents then had a conventional karyotype performed.
Results In each case, parental karyotyping revealed the pres-
ence of an otherwise unknown balanced translocation. Origi-
nal blastocyst CCS results were then reinterpreted to consider
the presence of unbalanced derivative chromosomes and to
modify the diagnosis of embryos eligible for transfer.
Conclusions It is possible to identify patients that are car-
riers of balanced translocations through the analysis of chro-
mosomes in their IVF-derived embryos. Given that
translocation carrier screening is not routinely performed,
the growing use of CCS may facilitate discovery and pro-
vide both an etiology of reproductive failure and an im-
proved more focused treatment strategy going forward.
Future work will involve a large retrospective study to
define the sensitivity and frequency of detection using this
methodology.
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Introduction
Carriers of balanced translocations are at an increased risk for
miscarriage and producing offspring with congenital abnor-
malities and mental retardation, as a result of unbalanced
segregation during gametogenesis [1]. Although individuals
with infertility may have a higher risk of carrying a balanced
translocation relative to the general population [2], carrier
screening is not routinely performed without a more definitive
indication such as recurrent pregnancy loss [3, 4], where
approximately 0.5–5 % of couples carry a balanced
rearrangement [5]. Most often, patients carrying a transloca-
tion are identified after a miscarriage when genetic analysis of
Capsule Carriers of balanced translocations are at increased risk of
infertility due to the production of unbalanced gametes. While carriers
are most often identified through family history, a history of recurrent
pregnancy loss or genetic analysis of an unbalanced fetus, this study
describes 3 cases where incidental identification resulted from having
performed comprehensive chromosome screening on IVF-derived
embryos.
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the products of conception reveals segmental chromosome
imbalances. In those situations, parental karyotyping is or-
dered. Other individuals may have a family history leading
to their referral for karyotyping prior to attempting conception.
Once identified, in vitro fertilization (IVF) with preimplanta-
tion genetic diagnosis is a highly effective option for carriers
of balanced translocations [6, 7]. However, to our knowledge,
the identification of segmental imbalances in preimplantation
embryos has not been reported as a source of information
leading to the identification of individuals carrying a balanced
translocation. This report describes 3 such cases where inci-
dental findings following comprehensive chromosome
screening (CCS) in IVF-derived embryos led to the identifi-
cation of patients carrying balanced translocations.
Materials and methods
CCS
Patients indicated for CCS had IVF with blastocyst
biopsy and either fresh embryo transfer or vitrifcation
as previously described [8]. Trophectoderm biopsies
were evaluated using a previously validated method of
either SNP microarray-based [9] or quantitative real-
time (q)PCR-based [10] CCS. Cases in which at least
2 embryos where observed to potentially possess seg-
mental aneuploidies within the same genomic regions
were identified as indicated for parental karyotyping.
Conventional karyotyping
G-banding was performed on each couple at one of 3 com-
mercial reference laboratories; LabCorp Molecular Biology
and Pathology (North Carolina), Columbia University Med-
ical Center Campus of the New York Presbyterian Hospital
(New York), or Integrated Genetics-Esoterix Genetic Labo-
ratories, LLC (New Mexico). In each case, once a parental
karyotype confirmed a balanced translocation carrier status,
embryo CCS results were reinterpreted accordingly.
Results
In 3 cases, a balanced translocation carrier status was con-
firmed by conventional karyotyping after IVF-derived em-
bryo based CCS indicated the possibility (Fig. 1). In each
case, the original CCS results were reinterpreted to assign
additional predictions of the inheritance of translocated
chromosomes for each embryo (Table 1).
Case 1 was a 37 year old gravida 1 para 1 who presented
with longstanding secondary infertility with a new partner.
The male partner was a 48 year old with prior paternity in a
previous relationship who was found to have severe
oligospermia on repeat semen analyses. The couple’s existing
child was phenotypically normal. The patient underwent an
IVF stimulation with final oocyte maturation achieved with
leuprolide acetate due to risk of ovarian hyperstimulation
(OHSS). A total of 58 oocytes were retrieved, of which 38
underwent ICSI and 33 fertilized normally. Due to the OHSS
risk, nine blastocysts underwent trophectoderm biopsy and
vitrification. After SNP microarray analysis, 3 embryos were
predicted to be aneuploid. Four of the embryos had consistent
segmental imbalances on chromosome 3. A conventional
karyotype of the parents was ordered and confirmed a mater-
nal balanced translocation, 46,XX,t(3;16)(p25.3;q24.3).
When viewed in isolation, these segmental imbalances would
not have altered the overall copy number call for chromosome
3. However, once a balanced translocation was documented
on conventional karyotype, the CCS results were reinterpreted
using a previously established analysis protocol for transloca-
tion carriers [6]. After re-analysis, there were 4 embryos
predicted to be balanced or normal, one of which was warmed
for frozen embryo transfer and she currently has an ongoing
singleton pregnancy.
Case 2 was a 39 year old nulligravida who presented with
longstanding unexplained infertility. She underwent 2 cycles
of controlled ovarian hyperstimulation and timed intrauter-
ine insemination without resulting in a pregnancy. She then
underwent an IVF stimulation with planned CCS using a
GnRH agonist downregulation protocol. She had 32 oocytes
retrieved, of which 25 underwent ICSI and 21 normally
fertilized. Four blastocysts were biopsied and vitrified. On
subsequent qPCR analysis, 2 were predicted to be aneuploid
(47,XX,+22; 46,XY,-10,+13). One embryo was predicted to
be euploid and the data on the forth embryo was determined
to be non-concurrent based on previously established
thresholds. She underwent another cycle in an attempt to
accrue additional euploid blastocysts for future frozen trans-
fer. In the next cycle, with a similar protocol, she produced
8 blastocysts that underwent trophectoderm biopsy. On
analysis of the embryos, there were consistent segmental
imbalances involving the distal regions of chromosomes 10
and 13. These observations prompted a recommendation for
parental chromosome analysis which revealed a maternal
balanced translocation, 46,XX,t(10;13)(q24.3;q12.1). In
light of this finding, none of the embryos were suitable for
transfer as 2 were aneuploid and 6 showed evidence of
carrying unbalanced translocation derivative chromosomes.
Furthermore, re-analysis of the qPCR data from the first IVF
cycle revealed that the previously predicted normal and non-
concurrent embryos both carried the unbalanced transloca-
tion. The patient underwent a final IVF cycle, this time at
age 40, with additional Taqman PCR primers for the trans-
location so that at least 4 assays on each side of the
breakpoints for each of the two chromosomes involved in
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A. Case 1 





















































C. Case 3 





















D. Case 1 46,XX,t(3;16)(p25.3;q24.3) 
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18
19 20 21 22 X Y
E. Case 2 46,XX,t(10;13)(q24.3;q12.1) 
1
2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18
19 20 21 22 X Y
F.Case 3 46,XY,t(2;18)(p13.1;q12.2) 
1 2 43 5
6 7 8 9 10 11 12
13 14 15 16 17 18
19 20 21 22 X Y
Fig. 1 Results of embryo CCS (a–c) and parental karyotyping (d–f)
for 3 cases reported in this study. Black arrows indicate regions of
imbalance in SNP array based CCS plots (a and c), while black boxes
highlight chromosomes with segmental imbalance in qPCR based CCS
heatmaps (b). In the qPCR heatmaps, the lowest copy number (zero) is
indicated by the most intense red color while the highest copy number
(4.6) is indicated by a white color. Copy number changes are indicated
by changes in color intensity from red-orange-yellow-white with an
orange color indicating a copy number of 2, red-like color indicating
reduced copy number relative to 2, and yellow-like color indicating
increased copy number relative to 2. Grey indicates no amplification.
The heatmaps are organized (from left to right and top to bottom) from
chromosome 1 on the top left to chromosome Y on the bottom right,
with each chromosome having 4 loci evaluated and 4 replicate re-
actions per loci (16 total data points per chromosome and 384 data
points per embryo)
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the translocation were included. Ten blastocysts underwent
biopsy and qPCR, however all were unbalanced. The patient
finally delivered after proceeding with oocyte donation.
The third patient presented as a 38 year old with primary
infertility. Her partner was 41 years old and found to have
teratozoospermia on semen analysis. She underwent an IVF
cycle with a GnRH antagonist protocol and 12 mature
oocytes were retrieved, of which 9 fertilized normally with
ICSI. She produced 4 blastocysts that had trophectoderm
biopsy performed. SNP microarray analysis revealed 1 eu-
ploid embryo and 3 embryos with a pattern of segmental
imbalance on the distal regions of chromosomes 2 and 18
that was consistent with an unbalanced translocation. Paren-
tal chromosome analysis was ordered and revealed a pater-
nal balanced translocation, 46,XY,t(2;18)(p13.1;q12.2). The
single predicted euploid or balanced embryo was transferred
and led to the delivery of a healthy female.
Discussion
This study has demonstrated that it is possible to use IVF-
derived embryo CCS analysis to identify certain patients at
risk of carrying a balanced translocation. In each case, the
discovery provided both an etiology for reproductive failure
and a more focused treatment strategy. Furthermore, in the 3
cases reported here, 3 embryos originally found to be suitable
for transfer based on criteria for assessing only whole chro-
mosome aneuploidy were subsequently predicted to possess
an unbalanced karyotype given the newly obtained transloca-
tion carrier status of the parents. The refinement of the original
predicted karyotype in these cases may have averted a poten-
tial miscarriage or possibly the delivery of an affected child.
With the growing use of CCS to improve the success of
IVF, it may be useful to establish criteria for recommending
parental karyotyping based on observations made in embry-
os as demonstrated in this case report series. To this end,
future work will involve a retrospective study of a large
number of CCS cases in order to develop such criteria and
determine sensitivity to and frequency of detecting cases
indicated for translocation carrier screening. Results will
be influenced by multiple factors including the CCS plat-
form utilized (q-PCR or microarray) and its concomitant
diagnostic resolution (i.e. limits of detection of small seg-
mental aneuploidies associated with unbalanced transloca-
tions), as well as having a sufficient number of embryos
Table 1 Embryo CCS results of
3 cases leading to an indication
and identification of a parent
with a balanced translocation
AIncluded in Fig. 1
BDiagnosis impacted
Case No. Embryo No. Original CCS predicted karyotype Revised CCS predicted karyotype
1 1 46,XX 46,XX or 46,XX,t(3;16)(p25.3;q24.3)
2 46,XX 46,XX or 46,XX,t(3;16)(p25.3;q24.3)
3 46,XY 46,XY or 46,XY,t(3;16)(p25.3;q24.3)
4 47,XX,+16 47,XX,+16
5A 45,XX,-6 45,XX,der[3]t(3;16)(p25.3;q24.3),-6
6 A 45,XY,-19 45,XY,der(16)t(3;16)(p25.3;q24.3),-19
7 46,XX 46,XX or 46,XX,t(3;16)(p25.3;q24.3)
8 A 46,XY 46,XY,der(16)t(3;16)(p25.3;q24.3) B
9 A 46,XX 46,XX,der[3]t(3;16)(p25.3;q24.3) B
2 1 47,XX,+22 47,XX,+22
2 A 46,XX 47,XX,+der(13)t(10;13)(q24.3;q12.1) B
3 nonconcurrent 46,XY,der(13)t(10;13)(q24.3;q12.1)B
4 46,XX,-10,+13 46,XX,-10,+13
5 A 47,XX,+10 46,XX,+der[10]t(10;13)(q24.3;q12.1),-13
6 47,XY,+13 47,XY,+13
7 46,XX,+10,-13 46,XX,t(10;13)(q24.3;q12.1)




12 47,XX,+10 46,XX,+der[10] t(10;13)(q24.3;q12.1),-13
3 1 46,XX 46,XX or 46,XX,t(2;18)(p13.1;q12.2)
2 A 45,XY,-2 46,XY,-2,+der(18)t(2;18)(p13.1;q12.2)
3 A 45,XX,-2 46,XX,-2,+der(18)t(2;18)(p13.1;q12.2)
4 A 44,XY,-2,-18 45,XY,-2,der(18)t(2;18)(p13.1;q12.2)
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evaluated within each case in order to observe imbalances
within the same segment in more than one embryo. Given
the demonstrated ability of CCS to improve single embryo
transfer outcomes [11], the indications for CCS may be
expanding. Patients without a prior indication for conven-
tional karyotyping are increasingly using this technology.
Nonetheless, this strategy is not necessarily meant to replace
conventional karyotyping of indicated patients since CCS
may not be indicated for all patients undergoing IVF. In-
stead, once a couple has already undergone an IVF cycle
using CCS, it may be possible to evaluate whether parental
translocation screening is indicated based upon observations
made in the embryos produced.
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